The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 4 Evaluation of neurological deficit progress among study group throughout study duration

From: The use of dexamethasone therapy for conservative management of chronic subdural hematomas: a question about efficacy and safety

Measurements	Chi-square test	p-value
Day 1 vs. Day 14	1.172	0.279
Day 1 vs. 1 M	1.875	0.171
Day 1 vs. 3 M	10.851	< 0.001**
Day 1 vs. 6 M	13.694	< 0.001**
Day 14 vs. 1 M	0.054	0.815
Day 14 vs. 3 M	4.484	0.034*
Day 14 vs. 6 M	6.816	0.009*
1 M vs. 3 M	3.423	0.064
1 M vs. 6 M	5.608	0.018*
3 M vs. 6 M	0.483	0.487

Using: Chi-square test
p-value > 0.05 is insignificant; *p-value < 0.05 is significant; **p-value < 0.001 is highly significant
M months after protocol initiation

Back to article page